-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on NeoGenomics, Raises Price Target to $14

Benzinga·04/29/2026 18:17:41
Listen to the news
TD Cowen analyst Dan Brennan maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $13 to $14.